979-P: Improved Technology Satisfaction and Sleep Quality with Medtronic Minimed Advanced Hybrid Closed-Loop Delivery Compared with Predictive Low Glucose Suspend in People with Type 1 Diabetes in a Randomized Crossover Trial
العنوان: | 979-P: Improved Technology Satisfaction and Sleep Quality with Medtronic Minimed Advanced Hybrid Closed-Loop Delivery Compared with Predictive Low Glucose Suspend in People with Type 1 Diabetes in a Randomized Crossover Trial |
---|---|
المؤلفون: | Martin de Bock, Olivia J. Collyns, Benjamin J Wheeler, Chris Frampton, Carla M. Frewen, Shirley Jones, Dennis Chan, Natalie Kurtz, Robert A. Vigersky, Renee A. Meier, Niranjala M. Hewapathirana, Barbara C. Galland, John H. Shin, Zara L. Betts |
المصدر: | Diabetes. 69 |
بيانات النشر: | American Diabetes Association, 2020. |
سنة النشر: | 2020 |
مصطلحات موضوعية: | 0301 basic medicine, medicine.medical_specialty, Type 1 diabetes, business.industry, Endocrinology, Diabetes and Metabolism, 030209 endocrinology & metabolism, Hypoglycemia, medicine.disease, Crossover study, law.invention, Pittsburgh Sleep Quality Index, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, Randomized controlled trial, Quality of life, law, Diabetes mellitus, Internal Medicine, medicine, Physical therapy, business, Glycemic |
الوصف: | Background: Automated insulin delivery aims to lower treatment burden and improve quality of life as well as glycemic outcomes. Methods: This dual-centre, randomized, open-label, two-sequence cross-over study in automated insulin delivery naïve users, compared Medtronic Minimed® Advanced Hybrid Closed Loop (AHCL) to Sensor Augmented Pump therapy with Predictive Low Glucose Management (SAP+PLGM). At the end of each 4 week intervention impacts on quality of life were compared using age-appropriate scales: Diabetes Treatment Satisfaction Questionnaire status and change (DTSQs and DTSQc), Diabetes Technology Questionnaire (DTQ), Pittsburgh Sleep Quality Index (PSQI), World Health Organisation-Five Well-Being Index (WHO-5), Hypoglycemic Fear Survey (HFS-II) and Hypoglycemia Confidence Scale (HCS). Results: 59/60 people completed the study (mean age 23.3±14.4yrs). Statistically significant differences favouring AHCL were demonstrated in several scales (data shown as mean±SE). Technology satisfaction favoured AHCL over PLGM as shown by a higher score in the DTSQs during AHCL (n=28) vs. SAP+PLGM (n=29) (30.9±0.7 vs. 27.9±0.7, p=0.004) and DTSQc AHCL (n=29) vs. SAP+PLGM (n=30) (11.7±0.9 vs. 9.2±0.8, p=0.032) in adults. Adolescents also showed a higher DTSQc score during AHCL (n=16) vs. SAP+PLGM (n=15) (14.8±0.7 vs. 12.1±0.8, p=0.024). The DTQ “change” score (n=59) favoured AHCL over SAP+ PLGM (3.5±0.0 vs. 3.3±0.0, p 5 indicating poor quality sleep. No differences were found in the other scales. Conclusion: The findings from this RCT suggest AHCL compared to SAP + PLGM mode has the potential to increase treatment satisfaction and improve subjective sleep quality in adolescents and adults with T1D. Disclosure O. Collyns: None. R. Meier: None. Z. Betts: None. D. Chan: None. C. Frampton: None. C.M. Frewen: None. B. Galland: None. N. Hewapathirana: Other Relationship; Self; Sanofi. S. Jones: None. N. Kurtz: Employee; Self; Medtronic. J. Shin: Employee; Self; Medtronic. R. Vigersky: Employee; Self; Medtronic. B.J. Wheeler: Research Support; Self; Medtronic. M. de Bock: None. |
تدمد: | 1939-327X 0012-1797 |
الوصول الحر: | https://explore.openaire.eu/search/publication?articleId=doi_________::0bd41c6618091b1b8e453b140f49cd68Test https://doi.org/10.2337/db20-979-pTest |
حقوق: | CLOSED |
رقم الانضمام: | edsair.doi...........0bd41c6618091b1b8e453b140f49cd68 |
قاعدة البيانات: | OpenAIRE |
تدمد: | 1939327X 00121797 |
---|